Skip to main content

Iterum Therapeutics plc

ITRMDelisted Jun 23, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001659323

Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.

Q1 2024 vs. Q4 2023

How the institutions holding Iterum Therapeutics plc changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of ITRM: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders1618+2
Shares386.6K928.8K+542.2K (+140.2%)
Value$761.6K$1.43M+$668.7K (+87.8%)

New holders (5)

Institutions that held Iterum Therapeutics plc at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to ITRM in Q1 2024
InstitutionSharesValue% of portfolio
Point72 Asset Management, L.P.434,000$668.4K0.00%
Millennium Management LLC28,043$43.2K0.00%
Vontobel Holding Ltd.15,000$23.1K0.00%
Tower Research Capital LLC (TRC)468$7210.00%
Blue Bell Private Wealth Management, LLC66$1020.00%

Sold out (3)

Institutions that held Iterum Therapeutics plc at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of ITRM in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Susquehanna International Group, LLP17,533$34.5K
GWM Advisors LLC100$197
Cypress Capital Management LLC (WY)66$130